StockData
RenovoRx, Inc. logo

RenovoRx, Inc. (RNXT) stock

RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.04+0.09 (+8.91%)

Close on Nov 17, 2026Market cap $46.93MP/E –Yield –

RenovoRx revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

RenovoRx's revenue for the twelve months ending Jun 30, 2026 was $1.98M. For fiscal 2025 it was $1.12M, up 2511.6% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.12M+2511.6%
FY2024Dec 31, 2024$43.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$909.00K+115.4%
Q1 FY2026Mar 31, 2026$563.00K+185.8%
Q4 FY2025Dec 31, 2025$238.00K–
Q3 FY2025Sep 30, 2025$266.00K–
Q2 FY2025Jun 30, 2025$422.00K–
Q1 FY2025Mar 31, 2025$197.00K–

More RenovoRx figures

See a number that looks wrong?